Survival following radiotherapy in young women with localized early‐stage breast cancer according to molecular subtypes

• Published in: Cancer medicine (Malden, MA) Vol. 8; no. 6; pp. 2840 - 2857
• Main Authors: Liu, Qi‐Qi, Sun, He‐Fen, Yang, Xue‐Li, Chen, Meng‐Ting, Liu, Yang, Zhao, Yang, Zhao, Yuan‐Yuan, Jin, Wei
• Format: Journal Article
• Language: English
• Published: United States John Wiley & Sons, Inc 01.06.2019; John Wiley and Sons Inc; Wiley
• Subjects: Adult; Age; Biomarkers, Tumor; Breast cancer; Breast Neoplasms - diagnosis; Breast Neoplasms - epidemiology; Breast Neoplasms - mortality; Breast Neoplasms - radiotherapy; Cancer therapies; Chemotherapy; Clinical Cancer Research; Endocrine therapy; Epidemiology; Epidermal growth factor; ErbB-2 protein; Ethics; Female; Humans; Kaplan-Meier Estimate; Middle Aged; molecular subtype; Neoplasm Grading; Neoplasm Staging; Original Research; Patients; Prognosis; Radiation therapy; SEER Program; Studies; Surveillance; Survival; Treatment Outcome; Triple Negative Breast Neoplasms - genetics; Triple Negative Breast Neoplasms - mortality; Triple Negative Breast Neoplasms - pathology; Triple Negative Breast Neoplasms - radiotherapy; Young Adult; United States > US; breast cancer; molecular subtype; radiation therapy; survival
• ISSN: 2045-7634; 2045-7634
• DOI: 10.1002/cam4.2186

Background To evaluate the significance and benefit of radiotherapy (RT) in young early‐stage breast cancer patients according to different molecular subtypes. Methods We conducted a retrospective cohort study utilizing the Surveillance, Epidemiology, and End Results database with known hormone rece...